Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

This study has been completed.
Sponsor:
Collaborator:
McMaster University
Information provided by (Responsible Party):
Oren Cheifetz, McMaster University
ClinicalTrials.gov Identifier:
NCT01111032
First received: April 26, 2010
Last updated: September 29, 2013
Last verified: September 2013
  Purpose

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.


Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.

Resource links provided by NLM:


Further study details as provided by McMaster University:

Primary Outcome Measures:
  • STEEP treadmill test [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
    Treadmill test for endurance. Lasts approx 15 min with 45 min recovery


Enrollment: 12
Study Start Date: May 2011
Study Completion Date: December 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Treadmill test

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult well cancer survivors

Criteria

Inclusion Criteria:

  • Participants are required to be adults (age 16 or over),
  • Diagnosed with cancer, at any stage of treatment (during or after treatment),
  • Able to follow instructions in English, and provide informed consent.
  • Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion Criteria:

  • Cancer survivors with metastatic disease.
  • Cancer survivors who are defined as unwell.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01111032

Locations
Canada, Ontario
Hamilton Health Sciences, Henderson Campus
Hamilton, Ontario, Canada, L8V 1C3
Sponsors and Collaborators
Hamilton Health Sciences Corporation
McMaster University
Investigators
Principal Investigator: Oren Cheifetz, M.Sc. PT Hamilton Health Sciences Corporation
  More Information

No publications provided

Responsible Party: Oren Cheifetz, Clinical Specialist - Physiotherapy, McMaster University
ClinicalTrials.gov Identifier: NCT01111032     History of Changes
Other Study ID Numbers: Treadmill Comparison
Study First Received: April 26, 2010
Last Updated: September 29, 2013
Health Authority: Canada: Ethics Review Committee

Keywords provided by McMaster University:
Treadmill
Exercise
Cancer
Validity
Reliability

ClinicalTrials.gov processed this record on October 23, 2014